Braidwell LP Day One Biopharmaceuticals, Inc. Transaction History
Braidwell LP
- $3.1 Trillion
- Q1 2024
A detailed history of Braidwell LP transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Braidwell LP holds 2,173,704 shares of DAWN stock, worth $28.8 Million. This represents 1.16% of its overall portfolio holdings.
Number of Shares
2,173,704
Previous 4,215,573
48.44%
Holding current value
$28.8 Million
Previous $61.5 Billion
41.66%
% of portfolio
1.16%
Previous 2.26%
Shares
6 transactions
Others Institutions Holding DAWN
# of Institutions
148Shares Held
60MCall Options Held
47.7KPut Options Held
61.3K-
Atlas Venture Life Science Advisors, LLC6.43MShares$85.3 Million13.29% of portfolio
-
Black Rock Inc. New York, NY5.03MShares$66.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.77MShares$63.4 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.81MShares$50.5 Million0.02% of portfolio
-
State Street Corp Boston, MA2.89MShares$38.4 Million0.0% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $975M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...